Overview
Mounjaro is a branded tirzepatide product. Whether it is appropriate for you is a clinical decision made by your SHWCare provider.
What Mounjaro is
Mounjaro is a dual GIP/GLP-1 receptor agonist branded product. FDA-approved indications and prescribing considerations are reviewed by your clinician.
How it works
As a tirzepatide product, Mounjaro engages two appetite-and-glucose pathways instead of one.
When a clinician may consider it
Whether tirzepatide or semaglutide is more appropriate depends on your individual situation as evaluated by your provider.
Side effects discussed during review
Side effects are consistent with the tirzepatide class. A full discussion happens with your clinician.
Cost & access
Branded-product pricing varies. The care team will help review options.


